- Home
- ANAB vs FLNG Comparison
ANAB vs FLNG Comparison
Compare ANAB & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANAB | FLNG |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ANAB | FLNG |
|---|---|---|
| Price | $55.14 | $27.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $62.20 | $23.00 |
| AVG Volume (30 Days) | ★ 436.9K | 384.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $135.51 | $1.58 |
| Revenue Next Year | N/A | $2.54 |
| P/E Ratio | ★ N/A | $19.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.99 | $19.46 |
| 52 Week High | $57.65 | $27.67 |
Technical Indicators
Market Signals| Indicator | ANAB | FLNG |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 60.60 |
| Support Level | $46.85 | $25.41 |
| Resistance Level | $57.65 | $26.71 |
| Average True Range (ATR) | 3.51 | 0.65 |
| MACD | 0.48 | 0.01 |
| Stochastic Oscillator | 81.16 | 95.86 |
Price Performance
Historical ComparisonAbout ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with tonnage offering advantages in form of reduced fuel consumption and lowered boil-off rates.